Point of Care Testing Is Rewriting the Contract Manufacturing Playbook

Point of Care Testing (POCT) has moved from a niche convenience to a central pillar of modern diagnostics. Rapid tests delivered at the bedside, in clinics, and increasingly in patients' homes demand devices that are small, intuitive, and manufacturable at scale—often with short development cycles. This is fundamentally different from the large, stationary analysers that defined the IVD era, and it is forcing contract manufacturers to rethink their capabilities, tooling, and quality systems.

The Diagnostic Device Contract Manufacturing Market is being reshaped by POCT's rapid growth, which is outpacing traditional IVD. While IVD remains the largest application segment, POCT is the fastest-growing, driven by demand for rapid results and decentralised care. This shift favours manufacturers with expertise in microfluidics—still the dominant technology in the market—because miniaturising fluid handling is essential for portable devices. Genomics, meanwhile, is the fastest-growing technology segment, opening new opportunities for manufacturers capable of supporting next-generation sequencing workflows in compact formats.

The end-use picture reinforces this trend. Hospitals remain the dominant channel, accounting for the largest share of contract manufacturing demand, because they require high volumes of reliable devices for inpatient diagnostics. But home care is the fastest-growing end-use segment, driven by ageing populations and the expansion of remote monitoring and self-testing. For contract manufacturers, this dual reality—serving high-volume hospital contracts while also supporting low-volume, high-complexity home devices—is both a challenge and an opportunity. Companies that invest in flexible production lines, advanced automation, and AI-driven quality control will be positioned to capture the fast-growing POCT and home care segments as the market expands toward USD 22.3 billion by 2035.

People Also Ask

• Why is point of care testing growing so quickly?
  POCT delivers rapid results at or near the patient, improving clinical decision-making and reducing dependence on central laboratories.

• What manufacturing capabilities does POCT require?
  POCT requires microfluidics expertise, miniaturised electronics integration, and flexible, low-to-medium volume production lines.

Tags: #POCT #PointOfCareTesting #ContractManufacturing #Microfluidics #HomeCare #Diagnostics